{
  "id": 10935472,
  "title": "Tiziana Files For Orphan Drug Designation For Foralumab In MSA",
  "url": "https://urgent.news/2026/09/30/tiziana-files-for-orphan-drug-designation-for-foralumab-in-msa",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-30T11:36:43.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/tiziana-files-orphan-drug-designation-foralumab-msa"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Wednesday, Tiziana Life Sciences (TLSA) said it submitted a request to the FDA for Orphan Drug Designation for intranasal foralumab for the treatment of Multiple System Atrophy (MSA).",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}